Identification of tumoral glial precursor cells in neuroblastoma

Cancer Letters

Volumn 312, Issue 1, 2011, Pages 73-81

  Acosta, Sandra ^a   Mayol, Gemma ^a   Rodríguez, Eva ^a   Lavarino, Cinzia ^a   de Preter, Katleen ^b   Kumps, Candy ^b   Garcia, Idoia ^a   de Torres, Carmen ^a   Mora, Jaume ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Glial development; Neural crest precursor cells; Neuroblastoma; Neuroblasts differentiation; Tumor cell origin

Indexed keywords

CALCYCLIN; GANGLIOSIDE GD2; RETINOIC ACID;

ARTICLE; BONE MARROW METASTASIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SUBPOPULATION; GLIA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEUROBLAST; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL;

CELL CYCLE PROTEINS; CELL DIFFERENTIATION; GANGLIOSIDES; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; NEUROBLASTOMA; S100 PROTEINS;

EID: 80053316320     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.08.004     Document Type: Article

References (33)

1. De Preter K., Vandesompele J., Heimann P., Yigit N., Beckman S., Schramm A., Eggert A., Stallings R.L., Benoit Y., Renard M., De Paepe A., Laureys G., Påhlman S., Speleman F. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol. 2006, 7:R84.
2. Mora J., Gerald W.L. Origin of neuroblastic tumors: clues for future therapeutics. Expert Rev. Mol. Diagn. 2004, 4:293-302.
3. Shimada H., Umehara S., Monobe Y., Hachitanda Y., Nakagawa A., Goto S., Gerbing R.B., Stram D.O., Lukens J.N., Matthay K.K. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 2001, 92:2451-2461.
4. Maris JM., Hogarty MD., Bagatell R., Cohn SL. Neuroblastoma. Lancet 2007, 369:2106-2120.
5. Chlenski A., Liu S., Crawford SE., Volpert OV., DeVries GH., Evangelista A., Yang Q., Salwen HR., Farrer R., Bray J., Cohn SL. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002, 62:7357-7363.
6. Kwiatkowski J.L., Rutkowski J.L., Yamashiro D.J., Tennekoon G.I., Brodeur G.M. Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation. Cancer Res. 1998, 58:4602-4606.
7. Ambros I.M., Attarbaschi A., Rumpler S., Luegmayr A., Turkof E., Gadner H., Ambros P.F. Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med. Pediatr. Oncol. 2001, 36:163-168.
8. Mora J., Cheung N.K., Juan G., Illei P., Cheung I., Akram M., Chi S., Ladanyi M., Cordon-Cardo C., Gerald W.L., Neuroblastic Schwannian. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res. 2001, 61:6892-6898.
9. Ambros I.M., Zellner A., Roald B., Amann G., Ladenstein R., Printz D., Gadner H., Ambros P.F. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N. Engl. J. Med. 1996, 334:1505-1511.
10. Du W., Hozumi N., Sakamoto M., Hata J., Yamada T. Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells. Am. J. Pathol. 2008, 173:1153-1164.
11. Coco S., Defferrari R., Scaruffi P., Cavazzana A., Di Cristofano C., Longo L., Mazzocco K., Perri P., Gambini C., Moretti S., Bonassi S., Tonini G.P. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells. J. Pathol. 2005, 207:346-357.
12. Bourdeaut F., Ribeiro A., Paris R., Pierron G., Couturier J., Peuchmaur M., Delattre O. In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin. Oncogene 2008, 27:3066-3071.
13. Acosta S., Lavarino C., Paris R., Garcia I., de Torres C., Rodríguez E., Beleta H., Mora J. Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells. BMC Dev. Biol. 2009, 9:12.
14. Walton JD., Kattan DR., Thomas SK., Spengler BA., Guo HF., Biedler JL., Cheung NK., Ross RA. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004, 6:838-845.
15. Le Douarin N.M., Creuzet S., Couly G., Dupin E. Neural crest cell plasticity and its limits. Development 2004, 131:4637-4650.
16. Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973, 33:2643-2652.
17. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 1989, 49:219-225.
18. Ross R.A., Spengler B.A., Domènech C., Porubcin M., Rettig W.J., Biedler J.L. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ. 1995, 6:449-456.
19. Ross R.A., Spengler B.A. Human neuroblastoma stem cells. Semin. Cancer Biol. 2007, 17:241-247.
20. De Preter K., Speleman F., Combaret V., Lunec J., Laureys G., Eussen B.H., Francotte N., Board J., Pearson A.D., De Paepe A., Van Roy N., Vandesompele J. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Pathol. 2002, 15:159.
21. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007, 11:69-82.
22. Ferrari S., Tagliafico E., Manfredini R., Grande A., Rossi E., Zucchini P., Torelli G., Torelli U. Abundance of the primary transcript and its processed product of growth -related genes in normal and leukemic cells during proliferation and differentiation. Cancer Res. 1992, 52:11-16.
23. Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 2007, 282:31317-31331.
24. Joo JH., Yoon SY., Kim JH., Paik SG., Min SR., Lim JS., Choe IS., Choi I., Kim JW. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J. Cell Biochem. 2008, 103:1183-1197.
25. Morrison S.J., White P.M., Zock C., Anderson D.J. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999, 5:737-749.
26. Dráberová E., Del Valle L., Gordon J., Marková V., Smejkalová B., Bertrand L., de Chadarévian JP., Agamanolis DP., Legido A., Khalili K., Dráber P., Katsetos CD. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J. Neuropathol. Exp. Neurol. 2008, 67:341-354.
27. Påhlman S., Ruusala A.I., Abrahamsson L., Mattsson M.E., Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ. 1984, 14:135-144.
28. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 2009, 32:149-184.
29. Drozynska E., Izycka-Swieszewska E., Niedzwiecki M., Balcerska A., Perek D., Wachowiak J. A correlation of microvascular density and proliferative activity to clinical and histological characteristics in neuroblastoma. Neoplasma 2006, 53:247-252.
30. Chlenski A., Liu S., Cohn S.L. The regulation of angiogenesis in neuroblastoma. Cancer Lett. 2003, 197:47-52.
31. Hatzi E., Murphy C., Zoephel A., Rasmussen H., Morbidelli L., Ahorn H., Kunisada K., Tontsch U., Klenk M., Yamauchi-Takihara K., Ziche M., Rofstad EK., Schweigerer L., Fotsis T. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene 2002, 21:3552-3561.
32. Liu S., Tian Y., Chlenski A., Yang Q., Zage P., Salwen H.R., Crawford S.E., Cohn S.L. Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. Am. J. Pathol. 2005, 166:891-900.
33. Pezzolo A., Parodi F., Corrias M.V., Cinti R., Gambini C., Pistoia V. Tumor origin of endothelial cells in human neuroblastoma. J. Clin. Oncol. 2007, 25:376-383.